Carcidiag Biotech Overview
- Year Founded
-
2016
- Status
-
Out of Business
- Employees
-
8
- Latest Deal Type
-
Liquidation
Carcidiag Biotech General Information
Description
Developer of a diagnostic tool designed to detect cancerous and precancerous cells a few times and evaluate their aggressiveness. The company's diagnostic kit provides a technology that makes it possible to detect cancer affecting the ENT sphere as well as the colorectal area, enabling clinicians to constitute a significant advance in the characterization of the different stages of cancer and treat patients effectively.
Contact Information
Website
www.carcidiag.comCorporate Office
- 29 route de Courtille
- 23000 Gueret
- France
Corporate Office
- 29 route de Courtille
- 23000 Gueret
- France
Carcidiag Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Bankruptcy: Liquidation | 25-Oct-2022 | Completed | Bankruptcy: Liquidation | |||
| 4. Early Stage VC | 06-Apr-2018 | Completed | Generating Revenue | |||
| 3. Equity Crowdfunding | 01-Jan-2018 | Completed | Generating Revenue | |||
| 2. Debt - General | $584K | $584K | Completed | Generating Revenue | ||
| 1. Grant | 20-Jul-2017 | $171K | Completed | Generating Revenue |
Carcidiag Biotech Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary |
Carcidiag Biotech Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Carcidiag Biotech Patents
Carcidiag Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3093388-A1 | Method for isolating and detecting cancer stem cells | Pending | 08-Mar-2018 | ||
| WO-2019171010-A1 | Method for isolating and detecting cancer stem cells | Inactive | 08-Mar-2018 | ||
| FR-3078781-A1 | Method of isolation and detection of cancer stem cells | Active | 08-Mar-2018 | ||
| FR-3078781-B1 | Method of isolation and detection of cancerious stem cells | Active | 08-Mar-2018 | ||
| JP-2021516342-A | Methods for isolating and detecting cancer stem cells | Pending | 08-Mar-2018 | G01N33/57557 |
Carcidiag Biotech Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Carcidiag Biotech FAQs
-
When was Carcidiag Biotech founded?
Carcidiag Biotech was founded in 2016.
-
Where is Carcidiag Biotech headquartered?
Carcidiag Biotech is headquartered in Gueret, France.
-
What is the size of Carcidiag Biotech?
Carcidiag Biotech has 8 total employees.
-
What industry is Carcidiag Biotech in?
Carcidiag Biotech’s primary industry is Diagnostic Equipment.
-
Is Carcidiag Biotech a private or public company?
Carcidiag Biotech is a Private company.
-
What is Carcidiag Biotech’s current revenue?
The current revenue for Carcidiag Biotech is .
-
How much funding has Carcidiag Biotech raised over time?
Carcidiag Biotech has raised $3.3M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
